Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 35Colonic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 11Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 8Uterine Cervical Neoplasms 7Obesity 7Motor Activity 7Lung Neoplasms 7Overweight 6Depression 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Tobacco Use Disorder 4Sexuality 4Sexual Dysfunction, Physiological 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Depressive Disorder × Counseling × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡